Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Melanoma 14Glioblastoma 10Pancreatic Neoplasms 9Breast Neoplasms 9Neoplasms 8Glioma 8Prostatic Neoplasms 5Colonic Neoplasms 5Triple Negative Breast Neoplasms 4Squamous Cell Carcinoma of Head and Neck 4Ovarian Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Carcinoma 4Astrocytoma 4Oligodendroglioma 3Fallopian Tube Neoplasms 3Colorectal Neoplasms 3Central Nervous System Neoplasms 3Carcinoma, Merkel Cell 3Carcinoma, Hepatocellular 3Brain Neoplasms 3Urinary Bladder Neoplasms 2Stomach Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Osteosarcoma 2Neoplasms, Plasma Cell 2Neoplasm Metastasis 2Myelodysplastic Syndromes 2Lymphoma, T-Cell, Cutaneous 2

Interventions

Carmustine 2poly ICLC 1dapagliflozin 1Topotecan 1Tomography, X-Ray Computed 1Magnetoencephalography 1Magnetic Resonance Imaging 1High-Intensity Interval Training 1Diet, Ketogenic 1Cyclophosphamide 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Pediatric Brain Tumor × poly ICLC × Clear all
NCT03068832 2021-05-25

Neoepitope-based Personalized Vaccine Approach in Pediatric Patients With Recurrent Brain Tumors

Washington University School of Medicine

Phase 1 Withdrawn

Pediatric Brain Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡